Medivation's (MDVN) Talazoparib Acquisition is 'Good Use of Cash' - Maxim (BMRN)
Go back to Medivation's (MDVN) Talazoparib Acquisition is 'Good Use of Cash' - Maxim (BMRN)| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 58.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.79 | 52 Week High | $108.96 | |||
| Open | $58.79 | 52 Week Low | $62.12 | |||
| Day High | $58.79 | P/E | N/A | |||
| Day Low | $58.79 | EPS | $-1.27 | |||
| Volume | 1 | |||||
| Medivation, Inc. (NASDAQ: MDVN) | Delayed: 81.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.44 | 52 Week High | $81.48 | |||
| Open | $3852.47 | 52 Week Low | $26.41 | |||
| Day High | $81.44 | P/E | N/A | |||
| Day Low | $81.44 | EPS | $-1.03 | |||
| Volume | 13,593 | |||||
